231 related articles for article (PubMed ID: 12753499)
1. The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes.
Bregenholt S; Wang M; Wolfe T; Hughes A; Baerentzen L; Dyrberg T; von Herrath MG; Petersen JS
Scand J Immunol; 2003 May; 57(5):432-8. PubMed ID: 12753499
[TBL] [Abstract][Full Text] [Related]
2. Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein.
Meng Q; Wang W; Shi X; Jin Y; Zhang Y
Clin Dev Immunol; 2011; 2011():831704. PubMed ID: 21765853
[TBL] [Abstract][Full Text] [Related]
3. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes.
Holz A; Dyrberg T; Hagopian W; Homann D; von Herrath M; Oldstone MB
J Immunol; 2000 Nov; 165(10):5945-53. PubMed ID: 11067957
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
Ploix C; Bergerot I; Durand A; Czerkinsky C; Holmgren J; Thivolet C
Diabetes; 1999 Nov; 48(11):2150-6. PubMed ID: 10535448
[TBL] [Abstract][Full Text] [Related]
5. Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo.
Sadeghi H; Bregenholt S; Wegmann D; Petersen JS; Holmgren J; Lebens M
Immunology; 2002 Jun; 106(2):237-45. PubMed ID: 12047753
[TBL] [Abstract][Full Text] [Related]
6. Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice.
Presa M; Ortiz AZ; Garabatos N; Izquierdo C; Rivas EI; Teyton L; Mora C; Serreze D; Stratmann T
Eur J Immunol; 2013 Nov; 43(11):2969-79. PubMed ID: 23925934
[TBL] [Abstract][Full Text] [Related]
7. Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes.
Petersen JS; Bregenholt S; Apostolopolous V; Homann D; Wolfe T; Hughes A; De Jongh K; Wang M; Dyrberg T; Von Herrath MG
Clin Exp Immunol; 2003 Oct; 134(1):38-45. PubMed ID: 12974752
[TBL] [Abstract][Full Text] [Related]
8. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.
Aspord C; Thivolet C
Clin Exp Immunol; 2002 Nov; 130(2):204-11. PubMed ID: 12390307
[TBL] [Abstract][Full Text] [Related]
9. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
[TBL] [Abstract][Full Text] [Related]
10. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm.
Gong Z; Jin Y; Zhang Y
Vaccine; 2007 Feb; 25(8):1444-51. PubMed ID: 17113687
[TBL] [Abstract][Full Text] [Related]
11. Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes.
Liu B; Yue Y; Yang Y; Jin Y
PLoS One; 2016; 11(1):e0147260. PubMed ID: 26783749
[TBL] [Abstract][Full Text] [Related]
12. Insulin in oral immune "tolerance": a one-amino acid change in the B chain makes the difference.
Homann D; Dyrberg T; Petersen J; Oldstone MB; von Herrath MG
J Immunol; 1999 Aug; 163(4):1833-8. PubMed ID: 10438916
[TBL] [Abstract][Full Text] [Related]
13. Expression of cholera toxin B subunit and assembly as functional oligomers in silkworm.
Gong ZH; Jin HQ; Jin YF; Zhang YZ
J Biochem Mol Biol; 2005 Nov; 38(6):717-24. PubMed ID: 16336788
[TBL] [Abstract][Full Text] [Related]
14. Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes.
Kobayashi M; Abiru N; Arakawa T; Fukushima K; Zhou H; Kawasaki E; Yamasaki H; Liu E; Miao D; Wong FS; Eisenbarth GS; Eguchi K
J Immunol; 2007 Aug; 179(4):2082-8. PubMed ID: 17675466
[TBL] [Abstract][Full Text] [Related]
15. Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses.
Dénes B; Yu J; Fodor N; Takátsy Z; Fodor I; Langridge WH
Mol Biotechnol; 2006 Nov; 34(3):317-27. PubMed ID: 17284779
[TBL] [Abstract][Full Text] [Related]
16. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
17. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J
Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664
[TBL] [Abstract][Full Text] [Related]
18. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit.
Sun JB; Flach CF; Czerkinsky C; Holmgren J
J Immunol; 2008 Dec; 181(12):8278-87. PubMed ID: 19050244
[TBL] [Abstract][Full Text] [Related]
19. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J
Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes.
Gong Z; Jin Y; Zhang Y
J Biotechnol; 2005 Sep; 119(1):93-105. PubMed ID: 16024127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
